| | |||||
| disease | |||||
| 新闻 | |||||
| Ollin eyes phase 3 after topping Vabysmo in head-to-head trial - Fierce Biotech After unsheathing just a few months ago, Ollin Biosciences' next-gen bispecific antibody cleared more disease faster than Genentech's Vabysmo for ...
| |||||
| Neuropsychiatric symptoms in sporadic Creutzfeldt-Jakob disease | Brain - Oxford Academic Only 106 of 214 had the MMSE (as a marker of disease severity to allow comparison with other neurodegenerative diseases; see later) and the NPI done ...
| |||||
| 查看更多结果 | 修改此快讯 | |||||
| 您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
| 发送反馈 |
No comments:
Post a Comment